Abstract
Innovative drug treatments for malaria, optimally with novel targets, are needed to combat the threat of parasite drug resistance. As drug development efforts continue, there may be a role for a host-targeting, repurposed cancer drug administered together with an artemisinin combination therapy that was shown to improve the speed of recovery from a malaria infection.
| Original language | American English |
|---|---|
| Article number | e20211512 |
| Journal | Default journal |
| Volume | 218 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 6 2021 |
ASJC Scopus Subject Areas
- General Medicine
Keywords
- Antimalarials
- Artemisinins
- Drug Repositioning
- Drug Resistance
- Microbial
- Female
- Humans
- Imatinib Mesylate
- Malaria
- Falciparum
- Plasmodium falciparum
- Pregnancy
- Pregnancy Complications
- Parasitic
Disciplines
- Parasitic Diseases